Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — Diagnostics & Imaging. Per the activity note to the FY2024 annual report, the company provides laboratory and medical services, imports medical equipment, installs it, and wholesales pharmaceutical products.
Group parent — controls 1 company · ownership
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 0 | 0 | 516 | 117 | 0 | nmf |
| Net Cash used in Investing Activities | 0 | 0 | 662 | 94 | 0 | -85.7% |
| Free Cash Flow (OCF − Capex proxy) | 0 | 0 | 146 | 212 | 0 | +45.1% |
| Net Cash from Financing Activities | 0 | 0 | 110 | 91 | 0 | -17.5% |
| Net Change in Cash (before FX) | 0 | 0 | 36 | 121 | 0 | +238.0% |
| Effect of FX on Cash | 0 | 0 | 17 | 7 | 0 | nmf |
| Net Change in Cash (incl. FX) | 0 | 0 | 18 | 128 | 0 | +593.9% |
| Cash at Beginning of Year | 0 | 0 | 445 | 427 | 0 | -4.1% |
| Cash at End of Year | 0 | 0 | 427 | 299 | 0 | -29.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →